Abstract Title:

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.

Abstract Source:

Pediatr Infect Dis J. 2008 Nov;27(11):1030-2. PMID: 18845981

Abstract Author(s):

Debra J Hendrickson, Dean A Blumberg, Jesse P Joad, Sanjay Jhawar, Ruth J McDonald

Article Affiliation:

Department of Pediatrics, UC Davis Medical Center, Sacramento, CA, USA. [email protected]

Abstract:

A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61% of all post-2000 cases; 19% was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.